Anti-coagulant Factors Inhibits the Metastatic Activity of Tumor Cells
抗凝因子抑制肿瘤细胞的转移活性
基本信息
- 批准号:10672055
- 负责人:
- 金额:$ 2.05万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
By studies on the relation between expressions of anti-coagulant factors and metastatic activities of pancreatic tumor cells, BxPC-3, MIA PaCa-1, and PANC-2, following results were obtained.1. Tumor metastatic activity measured by use of chemotaxis chamber, which was divided by a kind of extracellular matrix coated on a filter, was highly dependent on the composition of the matrix, and BxPC-3 and MIA PaCa-1 cells prefer gelatin and vitronectin, respectively, for their inversion.2. BxPC-3 cells expressed continuously both thrombomodulin ? and tissue factor (TF), and the decrease and the increase in TM and TF, respectively, caused by treatment with various agents, such as TNF-α, IL-1β and PMA, correlated to the invasive activity.3. Treatment of BxPC-3 cells with anti-TM IgG and anti-TF IgG increased and decreased, respectively, the activity of the cells, whereas none of change was observed in MIA PaCa-1 cells treated with anti-TF pathway inhibitor IgG. Using monoclonal antibodies of TM, the inhibitory activity of TM against tumor inversion was thought to be associated with the domain that could be interacted with protein C. However, both activated protein C and degradation products of factor Va did not inhibit the tumor inversion.4. Transfection of expression plasmid of TM into MIA PaCa-1 cells, those were not expressed TM, resulted in does-dependent decrease in the invasive activity of the cells.5. Factor X and Xa did not enhance the metastatic activity of tumor cells, while factor VIIa increased the activity. The TF-dependent increase in the metastasis was blocked by the pretreatment with anti-VII IgG, indicating that the complex of TF-VIIa involved directly in intracellular signaling for the expression of matrix metalloproteases.
通过对胰腺癌细胞BxPC-3、MIA PaCa-1和PANC-2的抗凝血因子表达与转移活性关系的研究,得到以下结果.通过使用被一种包被在过滤器上的细胞外基质分隔的趋化室测量的肿瘤转移活性高度依赖于基质的组成,并且BxPC-3和MIA PaCa-1细胞分别偏好明胶和玻连蛋白用于其逆转. BxPC-3细胞持续表达血栓调节蛋白?TNF-α、IL-1β和PMA治疗后,TM和TF的降低和升高与侵袭性有关.用抗TM IgG和抗TF IgG处理BxPC-3细胞分别增加和降低细胞的活性,而在用抗TF途径抑制剂IgG处理的MIA PaCa-1细胞中没有观察到变化。利用TM的单克隆抗体,TM对肿瘤转化的抑制活性被认为与可与蛋白C相互作用的结构域有关。而活化蛋白C和Va因子降解产物均不能抑制肿瘤的转化.将TM的表达质粒转染到不表达TM的MIA PaCa-1细胞中,可使其侵袭活性呈剂量依赖性降低.因子X和Xa不增强肿瘤细胞的转移活性,而因子VIIa增强活性。TF依赖性增加的转移被阻断的预处理与抗-VII IgG,表明TF-VIIa的复合物直接参与细胞内信号传导的基质金属蛋白酶的表达。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HORIE Shuichi其他文献
HORIE Shuichi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HORIE Shuichi', 18)}}的其他基金
Analysis of the ability for memory-learning from a stand point of nutrrhythm and its basic research for prevention of senile dementia
从神经节律角度分析记忆学习能力及其预防老年性痴呆的基础研究
- 批准号:
23650490 - 财政年份:2011
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
ACTIVATION OF NUCLEAR RECEPTORS REGULATES ANITI THROMBOTIC ENVIRONMENT ON THE VASCULAR WALL
核受体的激活调节血管壁上的 ANITI 血栓环境
- 批准号:
14572067 - 财政年份:2002
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Transcriptional Regulation of Thrombomodulin by Interactions of the Gene Sequences with Nuclear Proteins
基因序列与核蛋白相互作用对血栓调节蛋白的转录调节
- 批准号:
06672202 - 财政年份:1994
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Studies on Regulation of Thrombomodulin on Expression in Cells Treated with Retinoic Acid
视黄酸处理细胞中血栓调节蛋白表达调控的研究
- 批准号:
03671064 - 财政年份:1991
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
- 批准号:
- 批准年份:2020
- 资助金额:56 万元
- 项目类别:面上项目
相似海外基金
The TGF-Beta/MUC4 Signaling Axis in Circulating Tumor Cells of Metastatic Breast Cancer
转移性乳腺癌循环肿瘤细胞中的 TGF-β/MUC4 信号轴
- 批准号:
10751169 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Research and development for clinical practical application by analysis of circulation tumor cells of hepatobiliary-pancreatic cancer
肝胆胰癌循环肿瘤细胞分析及临床应用研究进展
- 批准号:
23K14662 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Multicenter study of circulating tumor cells and circulating tumor DNA involved in distant metastasis of oral cancer
循环肿瘤细胞和循环肿瘤DNA参与口腔癌远处转移的多中心研究
- 批准号:
22H03292 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a novel personalized medicine platform using apheretically isolated circulating tumor cells to assess drug responsiveness in prostate cancer
开发一种新型个性化医疗平台,使用非血浆分离的循环肿瘤细胞来评估前列腺癌的药物反应
- 批准号:
10384366 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Microfluidic isolation and molecular analysis of circulating tumor cells for the study of neuroendocrine transdifferentiation in prostate cancer
循环肿瘤细胞的微流体分离和分子分析用于前列腺癌神经内分泌转分化的研究
- 批准号:
10399782 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Interleukin-1beta and AR-negative tumor cells in metastatic castrate-resistant prostate cancer
转移性去势抵抗性前列腺癌中白介素 1β 和 AR 阴性肿瘤细胞
- 批准号:
10686804 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Development of detection system for oral cancer patient's blood circulating tumor cells and prediction of clinical pathology and prognosis using it
口腔癌患者血液循环肿瘤细胞检测系统的开发及临床病理及预后预测
- 批准号:
22K10146 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Microfluidic isolation and molecular analysis of circulating tumor cells for the study of neuroendocrine transdifferentiation in prostate cancer
循环肿瘤细胞的微流体分离和分子分析用于前列腺癌神经内分泌转分化的研究
- 批准号:
10597026 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Interleukin-1beta and AR-negative tumor cells in metastatic castrate-resistant prostate cancer
转移性去势抵抗性前列腺癌中白介素 1β 和 AR 阴性肿瘤细胞
- 批准号:
10366584 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Detection of circulating tumor cells with a novel microfluidic system in patients with lung cancer
使用新型微流体系统检测肺癌患者的循环肿瘤细胞
- 批准号:
22K08987 - 财政年份:2022
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)